ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 660,44
1,62%
Dow Jones
39 331,85
0,00%
DAX
18 353,06
1,10%
Brent Oil
86,205
-0,28%
Bitcoin
60 204,85
-2,94%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Heat Biologics Inc (HTBX)

  7. Heat Biologics Inc (HTBX) Actualités

HTBX

Heat Biologics (HTBX)

Heat Biologics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:HTBX
DateHeureSourceTitreSymboleSociété
15/05/202322h34Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HTBXHeat Biologics Inc
15/05/202322h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HTBXHeat Biologics Inc
31/03/202322h15Edgar (US Regulatory)Annual Report (10-k)NASDAQ:HTBXHeat Biologics Inc
30/12/202222h06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:HTBXHeat Biologics Inc
09/12/202223h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HTBXHeat Biologics Inc
06/06/202222h29Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:HTBXHeat Biologics Inc
18/03/202212h35TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Biolase (BIOL), Heat Biologics (HTBX)NASDAQ:HTBXHeat Biologics Inc
11/03/202212h33Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)NASDAQ:HTBXHeat Biologics Inc
11/02/202223h17Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:HTBXHeat Biologics Inc
08/02/202223h04Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)NASDAQ:HTBXHeat Biologics Inc
02/02/202222h05GlobeNewswire Inc.Heat Biologics Announces Planned Transfer to the NYSE AmericanNASDAQ:HTBXHeat Biologics Inc
31/01/202213h30GlobeNewswire Inc.Elusys Therapeutics Finalizes HHS Contract to Deliver ANTHIM®, Its Treatment for Inhalation Anthrax, to the U.S. Department of Health and Human ServicesNASDAQ:HTBXHeat Biologics Inc
12/01/202214h00GlobeNewswire Inc.Heat Biologics Announces New PTX-35 Preclinical Data in Organ Transplantation and Provides Update on HS-110NASDAQ:HTBXHeat Biologics Inc
22/12/202113h05TipRanksB.Riley Financial Thinks Heat Biologics’ Stock is Going to RecoverNASDAQ:HTBXHeat Biologics Inc
21/12/202113h30GlobeNewswire Inc.Heat Biologics Announces Planned Acquisition of Elusys TherapeuticsNASDAQ:HTBXHeat Biologics Inc
30/11/202113h30GlobeNewswire Inc.Heat Biologics Unveils RapidVax®, A Novel Cellular Vaccine Platform Targeting Known and Unknown Emerging Biological ThreatsNASDAQ:HTBXHeat Biologics Inc
10/11/202122h05GlobeNewswire Inc.Heat Biologics Provides Third Quarter 2021 Business UpdateNASDAQ:HTBXHeat Biologics Inc
06/10/202113h30GlobeNewswire Inc.Heat Biologics Appoints Paul Tebbey as Senior Vice President of Product Development and Portfolio StrategyNASDAQ:HTBXHeat Biologics Inc
15/09/202113h30GlobeNewswire Inc.Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29thNASDAQ:HTBXHeat Biologics Inc
09/09/202114h30GlobeNewswire Inc.Heat Biologics to Present at the H.C. Wainwright 23rd Annual Global Investment ConferenceNASDAQ:HTBXHeat Biologics Inc
30/08/202113h30GlobeNewswire Inc.Heat Biologics to Provide Corporate UpdateNASDAQ:HTBXHeat Biologics Inc
26/08/202114h00GlobeNewswire Inc.Heat Biologics Unveils Skunkworx Bio, New Drug Discovery SubsidiaryNASDAQ:HTBXHeat Biologics Inc
23/08/202114h00GlobeNewswire Inc.Heat Biologics Announces Addition of Former US Senator Mark Pryor to Biothreat Advisory BoardNASDAQ:HTBXHeat Biologics Inc
19/08/202115h00GlobeNewswire Inc.Heat Biologics Announces New Additions to Biothreat Advisory BoardNASDAQ:HTBXHeat Biologics Inc
18/08/202114h00GlobeNewswire Inc.Heat Biologics Announces Formation of Biothreat Advisory BoardNASDAQ:HTBXHeat Biologics Inc
11/08/202122h05GlobeNewswire Inc.Heat Biologics Provides Second Quarter 2021 Business UpdateNASDAQ:HTBXHeat Biologics Inc
09/08/202113h30GlobeNewswire Inc.Heat Biologics Announces Groundbreaking for New San Antonio FacilityNASDAQ:HTBXHeat Biologics Inc
03/08/202122h43Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:HTBXHeat Biologics Inc
28/06/202113h30GlobeNewswire Inc.Heat Biologics Joins Russell Microcap® IndexNASDAQ:HTBXHeat Biologics Inc
23/06/202113h30GlobeNewswire Inc.Heat Biologics Announces Significant Expansion of R&D and Pre-Clinical Capabilities at Corporate HeadquartersNASDAQ:HTBXHeat Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:HTBX

Dernières Valeurs Consultées

LSE
AT01
Cred Ag Co 29
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés